Cerium dioxide nanoparticle exposure improves microvascular dysfunction and reduces oxidative stress in spontaneously hypertensive rats

Frontiers in Physiology

Volumn 6, Issue NOV, 2015, Pages

  Minarchick, Valerie C ^a   Stapleton, Phoebe A ^a   Sabolsky, Edward M ^b   Nurkiewicz, Timothy R ^a  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b West Virginia University   (United States)

Author keywords

Anti oxidant; Cerium dioxide nanoparticles; Hypertension; Microcirculation; Reactive oxygen species

Indexed keywords

ACETYLCHOLINE; ANTIOXIDANT; CERIUM OXIDE NANOPARTICLE; INTERLEUKIN 10; NITROPRUSSIDE SODIUM; REACTIVE OXYGEN METABOLITE; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTERIOLE; ARTICLE; CELL TRANSPORT; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOTHELIUM; FLUORESCENCE; HYPERTENSION; IN VIVO STUDY; INFLAMMATION; LEUKOCYTE; MALE; MESENTERIC ARTERIOLE; MICROANGIOPATHY; MICROSCOPY; NONHUMAN; OXIDATIVE STRESS; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; VASODILATATION; WISTAR KYOTO RAT;

EID: 84949565165     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2015.00339     Document Type: Article

References (50)

1. Bakker, E. N., Groma, G., Spijkers, L. J., de Vos, J., van Weert, A., van Veen, H., et al. (2014). Heterogeneity in arterial remodeling among sublines of spontaneously hypertensive rats. PLoS ONE 9:e107998. doi: 10.1371/journal.pone.0107998.
2. Benov, L., Sztejnberg, L., and Fridovich, I. (1998). Critical evaluation of the use of hydroethidine as a measure of superoxide anion radical. Free Radic. Biol. Med. 25, 826-831. doi: 10.1016/S0891-5849(98)00163-4.
3. Boegehold, M. A., and Bohlen, H. G. (1988). Arteriolar diameter and tissue oxygen tension during muscle contraction in hypertensive rats. Hypertension 12, 184-191. doi: 10.1161/01.HYP.12.2.184.
4. Bohlen, H. G., Henrich, H., Gore, R. W., and Johnson, P. C. (1978). Intestinal muscle and mucosal blood flow during direct sympathetic stimulation. Am. J. Physiol. 235, H40-H45.
5. Borm, P. J., Robbins, D., Haubold, S., Kuhlbusch, T., Fissan, H., Donaldson, K., et al. (2006). The potential risks of nanomaterials: a review carried out for ECETOC. Part. Fibre Toxicol. 3:11. doi: 10.1186/1743-8977-3-11.
6. Brito, R., Castillo, G., González, J., Valls, N., and Rodrigo, R. (2015). Oxidative stress in hypertension: mechanisms and therapeutic opportunities. Exp. Clin. Endocrinol. Diabetes 123, 325-335. doi: 10.1055/s-0035-1548765.
7. Celardo, I., Traversa, E., and Ghibelli, L. (2011). Cerium oxide nanoparticles: a promise for applications in therapy. J. Exp. Ther. Oncol. 9, 47-51.
8. Cho, W. S., Duffin, R., Poland, C. A., Howie, S. E., MacNee, W., Bradley, M., et al. (2010). Metal oxide nanoparticles induce unique inflammatory footprints in the lung: important implications for nanoparticle testing. Environ. Health Perspect. 118, 1699-1706. doi: 10.1289/ehp.1002201.
9. Colon, J., Herrera, L., Smith, J., Patil, S., Komanski, C., Kupelian, P., et al. (2009). Protection from radiation-induced pneumonitis using cerium oxide nanoparticles. Nanomedicine 5, 225-231. doi: 10.1016/j.nano.2008.10.003.
10. Colon, J., Hsieh, N., Ferguson, A., Kupelian, P., Seal, S., Jenkins, D. W., et al. (2010). Cerium oxide nanoparticles protect gastrointestinal epithelium from radiation-induced damage by reduction of reactive oxygen species and upregulation of superoxide dismutase 2. Nanomedicine 6, 698-705. doi: 10.1016/j.nano.2010.01.010.
11. Dunnick, K. M., Pillai, R., Pisane, K. L., Stefaniak, A. B., Sabolsky, E. M., and Leonard, S. S. (2015). The effect of cerium oxide nanoparticle valence state on reactive oxygen species and toxicity. Biol. Trace Elem. Res. 166, 96-107. doi: 10.1007/s12011-015-0297-4.
12. Estevez, A. Y., Pritchard, S., Harper, K., Aston, J. W., Lynch, A., Lucky, J. J., et al. (2011). Neuroprotective mechanisms of cerium oxide nanoparticles in a mouse hippocampal brain slice model of ischemia. Free Radic. Biol. Med. 51, 1155-1163. doi: 10.1016/j.freeradbiomed.2011.06.006.
13. Feghali, C. A., and Wright, T. M. (1997). Cytokines in acute and chronic inflammation. Front. Biosci. 2, d12-d26.
14. Félétou, M., and Vanhoutte, P. M. (2006). Endothelial dysfunction: a multifaceted disorder (The Wiggers Award Lecture). Am. J. Physiol. Heart Circ. Physiol. 291, H985-H1002. doi: 10.1152/ajpheart.00292.2006.
15. Gojova, A., Lee, J. T., Jung, H. S., Guo, B., Barakat, A. I., and Kennedy, I. M. (2009). Effect of cerium oxide nanoparticles on inflammation in vascular endothelial cells. Inhal. Toxicol. 21(Suppl. 1), 123-130. doi: 10.1080/08958370902942582.
16. Gottipolu, R. R., Wallenborn, J. G., Karoly, E. D., Schladweiler, M. C., Ledbetter, A. D., Krantz, T., et al. (2009). One-month diesel exhaust inhalation produces hypertensive gene expression pattern in healthy rats. Environ. Health Perspect. 117, 38-46. doi: 10.1289/ehp.11647.
17. Hayes, S. A., Yu, P., OKeefe, T. J., OKeefe, M. J., and Stoffer, J. O. (2002). The phase stability of cerium species in aqueous systems I. E-pH diagram for the Ce-HClO4-H2O system. J. Electrochem. Soc. 149, C623-C630. doi: 10.1149/1.1516775.
18. Heckert, E. G., Karakoti, A. S., Seal, S., and Self, W. T. (2008). The role of cerium redox state in the SOD mimetic activity of nanoceria. Biomaterials 29, 2705-2709. doi: 10.1016/j.biomaterials.2008.03.014.
19. Hirst, S. M., Karakoti, A. S., Tyler, R. D., Sriranganathan, N., Seal, S., and Reilly, C. M. (2009). Anti-inflammatory properties of cerium oxide nanoparticles. Small 5, 2848-2856. doi: 10.1002/smll.200901048.
20. Horie, M., Nishio, K., Kato, H., Fujita, K., Endoh, S., Nakamura, A., et al. (2011). Cellular responses induced by cerium oxide nanoparticles: induction of intracellular calcium level and oxidative stress on culture cells. J. Biochem. 150, 461-471. doi: 10.1093/jb/mvr081.
21. Hussain, S., Al-Nsour, F., Rice, A. B., Marshburn, J., Ji, Z., Zink, J. I., et al. (2012). Cerium dioxide nanoparticles do not modulate the lipopolysaccharide-induced inflammatory response in human monocytes. Int. J. Nanomed. 7, 1387-1397. doi: 10.2147/IJN.S29429.
22. Kelkar, S. S., and Reineke, T. M. (2011). Theranostics: combining imaging and therapy. Bioconjug. Chem. 22, 1879-1903. doi: 10.1021/bc200151q.
23. Kim, C. K., Kim, T., Choi, I. Y., Soh, M., Kim, D., Kim, Y. J., et al. (2012). Ceria nanoparticles that can protect against ischemic stroke. Angew. Chem. Int. Ed Engl. 51, 11039-11043. doi: 10.1002/anie.201203780.
24. LeBlanc, A. J., Cumpston, J. L., Chen, B. T., Frazer, D., Castranova, V., and Nurkiewicz, T. R. (2009). Nanoparticle inhalation impairs endothelium-dependent vasodilation in subepicardial arterioles. J. Toxicol. Environ. Health A. 72, 1576-1584. doi: 10.1080/15287390903232467.
25. LeBlanc, A. J., Moseley, A. M., Chen, B. T., Frazer, D., Castranova, V., and Nurkiewicz, T. R. (2010). Nanoparticle inhalation impairs coronary microvascular reactivity via a local reactive oxygen species-dependent mechanism. Cardiovasc. Toxicol. 10, 27-36. doi: 10.1007/s12012-009-9060-4.
26. Madero-Visbal, R. A., Alvarado, B. E., Colon, J. F., Baker, C. H., Wason, M. S., Isley, B., et al. (2012). Harnessing nanoparticles to improve toxicity after head and neck radiation. Nanomedicine 8, 1223-1231. doi: 10.1016/j.nano.2011.12.011.
27. Minarchick, V. C., Stapleton, P. A., Fix, N. R., Leonard, S. S., Sabolsky, E. M., and Nurkiewicz, T. R. (2015). Intravenous and gastric cerium dioxide nanoparticle exposure disrupts microvascular smooth muscle signaling. Toxicol. Sci. 144, 77-89. doi: 10.1093/toxsci/kfu256.
28. Minarchick, V. C., Stapleton, P. A., Porter, D. W., Wolfarth, M. G., Çiftyürek, E., Barger, M., et al. (2013). Pulmonary cerium dioxide nanoparticle exposure differentially impairs coronary and mesenteric arteriolar reactivity. Cardiovasc. Toxicol. 13, 323-337. doi: 10.1007/s12012-013-9213-3.
29. Morgan, A. R., Evans, D. H., Lee, J. S., and Pulleyblank, D. E. (1979). Review: ethidium fluorescence assay. Part II. enzymatic studies and DNA-protein interactions. Nucleic Acids Res. 7, 571-594. doi: 10.1093/nar/7.3.571.
30. Mosser, D. M. (2003). The many faces of macrophage activation. J. Leukoc. Biol. 73, 209-212. doi: 10.1189/jlb.0602325.
31. Nishikawa, Y., Stepp, D. W., and Chilian, W. M. (2000). Nitric oxide exerts feedback inhibition on EDHF-induced coronary arteriolar dilation in vivo. Am. J. Physiol. Heart Circ. Physiol. 279, H459-H465.
32. Niu, J., Wang, K., and Kolattukudy, P. E. (2011). Cerium oxide nanoparticles inhibit oxidative stress and nuclear factor-kappaB activation in H9c2 cardiomyocytes exposed to cigarette smoke extract. J. Pharmacol. Exp. Ther. 338, 53-61. doi: 10.1124/jpet.111.179978.
33. Nurkiewicz, T. R., Porter, D. W., Barger, M., Castranova, V., and Boegehold, M. A. (2004). Particulate matter exposure impairs systemic microvascular endothelium-dependent dilation. Environ. Health Perspect. 112, 1299-1306. doi: 10.1289/ehp.7001.
34. Nurkiewicz, T. R., Porter, D. W., Barger, M., Millecchia, L., Rao, K. M., Marvar, P. J., et al. (2006). Systemic microvascular dysfunction and inflammation after pulmonary particulate matter exposure. Environ. Health Perspect. 114, 412-419. doi: 10.1289/ehp.8413.
35. Nwankwo, T., Yoon, S. S., Burt, V., and Gu, Q. (2013). Hypertension Among Adults in the US: National Health and Nutrition Examination Survey, 2011-2012. NCHS Data Brief, 133. National Center for Health Statistics, Centers for Disease Control and Prevention, Hyattsville, MD, US Dept of Health and Human Services. Ref Type: Report.
36. Okamoto, K., Nosaka, S., Yamori, Y., and Matsumoto, M. (1967). Participation of neural factor in the pathogenesis of hypertension in the spontaneously hypertensive rat. Jpn. Heart J. 8, 168-180. doi: 10.1536/ihj.8.168.
37. Pagliari, F., Mandoli, C., Forte, G., Magnani, E., Pagliari, S., Nardone, G., et al. (2012). Cerium oxide nanoparticles protect cardiac progenitor cells from oxidative stress. ACS Nano. 6, 3767-3775. doi: 10.1021/nn2048069.
38. Park, E. J., Choi, J., Park, Y. K., and Park, K. (2008). Oxidative stress induced by cerium oxide nanoparticles in cultured BEAS-2B cells. Toxicology 245, 90-100. doi: 10.1016/j.tox.2007.12.022.
39. Parkington, H. C., Tare, M., and Coleman, H. A. (2008). The EDHF story: the plot thickens. Circ. Res. 102, 1148-1150. doi: 10.1161/CIRCRESAHA.108.177279.
40. Roco, M. C., Mirkin, C. A., and Hersam, M. C. (2010). Nanotechnology Research Directions for Societal Needs in 2020. Retrospective and Outlook. 9-30. World Technology Evaluation Center, Inc. Ref Type: Report.
41. Sanz-Rosa, D., Oubiña, M. P., Cediel, E., de Las Heras, N., Vegazo, O., Jiménez, J., et al. (2005). Effect of AT1 receptor antagonism on vascular and circulating inflammatory mediators in SHR: role of NF-kappaB/IkappaB system. Am. J. Physiol. Heart Circ. Physiol. 288, H111-H115. doi: 10.1152/ajpheart.01061.2003.
42. Sheikpranbabu, S., Kalishwaralal, K., Lee, K. J., Vaidyanathan, R., Eom, S. H., and Gurunathan, S. (2010). The inhibition of advanced glycation end-products-induced retinal vascular permeability by silver nanoparticles. Biomaterials 31, 2260-2271. doi: 10.1016/j.biomaterials.2009.11.076.
43. Stapleton, P. A., and Nurkiewicz, T. R. (2014). Vascular distribution of nanomaterials. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 6, 338-348. doi: 10.1002/wnan.1271.
44. Sun, D., Messina, E. J., Kaley, G., and Koller, A. (1992). Characteristics and origin of myogenic response in isolated mesenteric arterioles. Am. J. Physiol. 263(Pt 2), H1486-H1491.
45. Suzuki, H., Swei, A., Zweifach, B. W., and Schmid-Schonbein, G. W. (1995). In vivo evidence for microvascular oxidative stress in spontaneously hypertensive rats. hydroethidine microfluorography. Hypertension 25, 1083-1089. doi: 10.1161/01.HYP.25.5.1083.
46. Trickler, W. J., Lantz, S. M., Murdock, R. C., Schrand, A. M., Robinson, B. L., Newport, G. D., et al. (2010). Silver nanoparticle induced blood-brain barrier inflammation and increased permeability in primary rat brain microvessel endothelial cells. Toxicol. Sci. 118, 160-170. doi: 10.1093/toxsci/kfq244.
47. Wingard, C. J., Walters, D. M., Cathey, B. L., Hilderbrand, S. C., Katwa, P., Lin, S., et al. (2011). Mast cells contribute to altered vascular reactivity and ischemia-reperfusion injury following cerium oxide nanoparticle instillation. Nanotoxicology 5, 531-545. doi: 10.3109/17435390.2010.530004.
48. Xu, C., and Qu, X. (2014). Cerium oxide nanoparticle: a remarkably versatile rare earth nanomaterial for biological applications. NPG Asia Mater. 6, 1-16. doi: 10.1038/am.2013.88.
49. Yu, L., Scherlag, B. J., Dormer, K., Nguyen, K. T., Pope, C., Fung, K. M., et al. (2010a). Autonomic denervation with magnetic nanoparticles. Circulation 122, 2653-2659. doi: 10.1161/CIRCULATIONAHA.110.940288.
50. Yu, M., Mo, Y., Wan, R., Chien, S., Zhang, X., and Zhang, Q. (2010b). Regulation of plasminogen activator inhibitor-1 expression in endothelial cells with exposure to metal nanoparticles. Toxicol. Lett. 195, 82-89. doi: 10.1016/j.toxlet.2010.02.010.